ERBB2 and neoplasm: The expression of signature genes was verified in tumor tissues and paracancerous normal tissues from patients with TNBC (n=5), HER2+ breast cancer (n=5), and HR+ breast cancer (n=5) through immunofluorescence and Western blot.